✦ LIBER ✦

NFκB and ubiquitination: partners in disarming RIPK1-mediated cell death

✍ Scribed by Marie Anne O’Donnell, Adrian T. Ting

Book ID: 118821144
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 308 KB
Volume: 54
Category: Article
ISSN: 0257-277X
DOI: 10.1007/s12026-012-8321-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Linear ubiquitin chains: NF-κB signallin

Linear ubiquitin chains: NF-κB signalling, cell death and beyond

✍ Iwai, Kazuhiro; Fujita, Hiroaki; Sasaki, Yoshiteru 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 862 KB

Ubiquitination of RIP1 Regulates an NF-κ

Ubiquitination of RIP1 Regulates an NF-κB-Independent Cell-Death Switch in TNF Signaling

✍ Marie Anne O'Donnell; Diana Legarda-Addison; Penelopi Skountzos; Wen Chen Yeh; A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 965 KB

Role of NF-κB in p53-mediated programmed

Role of NF-κB in p53-mediated programmed cell death

✍ Ryan, Kevin M.; Ernst, Mary K.; Rice, Nancy R.; Vousden, Karen H. 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 292 KB

Functions of NF-κB1 and NF-κB2 in immune

Functions of NF-κB1 and NF-κB2 in immune cell biology

✍ BEINKE, Sören; LEY, Steven C. 📂 Article 📅 2004 🏛 Portland Press 🌐 English ⚖ 806 KB

NF-κB-mediated miR-30b regulation in car

NF-κB-mediated miR-30b regulation in cardiomyocytes cell death by targeting Bcl-2

✍ Wei, Chuanyu; Li, Li; Gupta, Sudhiranjan 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 477 KB

Vav-1 expression correlates with NFκB ac

Vav-1 expression correlates with NFκB activation and CD40-mediated cell death in diffuse large B-cell lymphoma cell lines

✍ Annette Hollmann; Raquel Aloyz; Kristi Baker; Stephan Dirnhofer; Trevor Owens; R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 439 KB

## Abstract Diffuse large B‐cell lymphoma (DLBCL) is an aggressive malignancy with a variable response to therapy. We have previously shown that DLBCL cell lines differ in their susceptibility to CD40‐mediated cell death, and that resistance to CD40‐targeted antibodies correlated with increased exp